These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 19276623

  • 1. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes.
    Yu AY, Keezer MR, Zhu B, Wolfson C, Côté R.
    Cerebrovasc Dis; 2009; 27(4):398-402. PubMed ID: 19276623
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
    Kumar S, Savitz S, Schlaug G, Caplan L, Selim M.
    Neurology; 2006 Apr 25; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
    [Abstract] [Full Text] [Related]

  • 3. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG.
    Neurology; 2007 May 15; 68(20):1687-93. PubMed ID: 17502550
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke.
    Keezer MR, Yu AY, Zhu B, Wolfson C, Côté R.
    Cerebrovasc Dis; 2008 May 15; 25(3):202-8. PubMed ID: 18212508
    [Abstract] [Full Text] [Related]

  • 5. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
    Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.
    Basic Clin Pharmacol Toxicol; 2012 Apr 15; 110(4):370-7. PubMed ID: 22023326
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
    Ovbiagele B, Kidwell CS, Starkman S, Selco SL, Rajajee V, Razinia T, Saver JL.
    Neurology; 2005 Sep 27; 65(6):851-4. PubMed ID: 16186522
    [Abstract] [Full Text] [Related]

  • 7. Premorbid antiplatelet use and ischemic stroke outcomes.
    Sanossian N, Saver JL, Rajajee V, Selco SL, Kim D, Razinia T, Ovbiagele B.
    Neurology; 2006 Feb 14; 66(3):319-23. PubMed ID: 16382033
    [Abstract] [Full Text] [Related]

  • 8. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M, Malmberg K, Ohrvik J, Rydén L, Euro Heart Survey Investigators.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr 14; 15(2):216-23. PubMed ID: 18391651
    [Abstract] [Full Text] [Related]

  • 9. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
    Fisher M, Folland E.
    Am J Ther; 2008 Apr 14; 15(2):137-49. PubMed ID: 18356634
    [Abstract] [Full Text] [Related]

  • 10. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
    Koton S, Molshatzki N, Bornstein NM, Tanne D.
    Cerebrovasc Dis; 2012 Apr 14; 34(3):213-20. PubMed ID: 23006641
    [Abstract] [Full Text] [Related]

  • 11. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
    Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.
    Clin Neuropharmacol; 2011 Apr 14; 34(6):234-40. PubMed ID: 21996648
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 13. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG, Vaidyanathan L, Kumar G, Bellolio MF, Brown RD, Suravaram S, Enduri S, Gilmore RM, Decker WW.
    J Stroke Cerebrovasc Dis; 2009 Oct 21; 18(2):124-7. PubMed ID: 19251188
    [Abstract] [Full Text] [Related]

  • 14. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
    Danchin N, Diévart F, Thébaut JF, Grenier O, Mihci E, Herrmann MA, Ferrières J.
    Int J Cardiol; 2009 Mar 20; 133(1):32-40. PubMed ID: 18375000
    [Abstract] [Full Text] [Related]

  • 15. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.
    Elkind MS, Flint AC, Sciacca RR, Sacco RL.
    Neurology; 2005 Jul 26; 65(2):253-8. PubMed ID: 16043795
    [Abstract] [Full Text] [Related]

  • 16. Rising statin use and effect on ischemic stroke outcome.
    Yoon SS, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J, Davis L, Baird AE.
    BMC Med; 2004 Mar 23; 2():4. PubMed ID: 15035663
    [Abstract] [Full Text] [Related]

  • 17. Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction.
    Fuentes B, Fernández-Domínguez J, Ortega-Casarrubios MA, SanJosé B, Martínez-Sánchez P, Díez-Tejedor E.
    J Hypertens; 2010 Mar 23; 28(3):575-81. PubMed ID: 20090554
    [Abstract] [Full Text] [Related]

  • 18. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events.
    Greisenegger S, Müllner M, Tentschert S, Lang W, Lalouschek W.
    J Neurol Sci; 2004 Jun 15; 221(1-2):5-10. PubMed ID: 15178206
    [Abstract] [Full Text] [Related]

  • 19. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M, Walker JH, Desjardins O, Robin AL, Covert DW, Bergamini MV, Einarson TR.
    Curr Med Res Opin; 2009 Aug 15; 25(8):1879-88. PubMed ID: 19530975
    [Abstract] [Full Text] [Related]

  • 20. Mean platelet volume in the early phase of acute ischemic stroke is not associated with severity or functional outcome.
    Ntaios G, Gurer O, Faouzi M, Aubert C, Michel P.
    Cerebrovasc Dis; 2010 Aug 15; 29(5):484-9. PubMed ID: 20299788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.